Navigation Links
NeoMatrix Announces Additional Funding for Breakthrough Breast Cancer Screening Test
Date:9/5/2007

>The Company also announced that Anthony Ciabattoni and Richard Franco have joined the NeoMatrix Board of Directors. According to Kathryn Tunstall, NeoMatrix's chairman, "Our board has been significantly strengthened by the addition of Tony and Richard. Each of them brings a wealth of operating experience and a set of valuable contacts that will benefit NeoMatrix as we continue to commercialize the HALO Breast Pap Test. I look forward to their active participation in the Company as we build market momentum and consider future financing to take the Company to profitability."

Anthony J. Ciabattoni is an entrepreneur with over 35 years of experience. He was the founder of Pacific Business Interiors, which became the largest distributor of Steelcase office furniture in Southern California, and a leading facilities management service provider to Fortune 500 companies. In addition to serving as president and CEO of Pacific Business Interiors from 1983 until its sale in 1996, Ciabattoni founded Recycled Office Solutions, a re-manufacturer of office furniture systems in 1993. Since selling those companies, he has been involved in a wide range of investments in the real estate, energy and private equity sectors. Ciabattoni serves as a member of the Board of Advisors for Waveland Capital Group, LLC, an investment banking firm that advises and raises capital for early stage medical technology companies, including NeoMatrix, LLC. Ciabattoni served as a director of Transeastern Properties, a real estate development company recently acquired by Technical Olympic USA, Inc. He received a bachelor's degree from the University of Delaware.

Richard A. Franco, Sr. has been a leader in the lifescience and health care industries for more than 30 years. He currently serves as president and CEO and a director of DARA BioSciences, Inc., a private pharmaceutical development company. From 1997 to 2002, Franco served as the Chairman of the Board of LipoScience, Inc. where he served
'/>"/>

SOURCE NeoMatrix, LLC
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...swire/ -- Stemline Therapeutics, Inc. today announ...3R targeting agents, SL-401 and SL-501, in both i...d leukemia (CML) have been selected for poster pre...he American Society of Hematology (ASH), to be hel...er will be presented by Stemline,s collaborators a...
(Date:12/3/2009)...Newswire-FirstCall/ -- VIA Pharmaceuticals, Inc. (...n the development of compounds for the treatment o...unced that it has completed the last patient visit.... ,, The FDG-PET trial enrolled 52 patients an...da including Massachusetts General Hospital, Mount...
(Date:12/3/2009)...ia, Dec. 3 /PRNewswire-Asia/ -- Dr. Susan Jiang, M...e Biotechnology Co. Ltd.,( http://www.beikebiotech...ic,Foot Care in New Delhi, India, November 22, 200... regenerative medicine company. , The con...ion (IPA), aimed,to help podiatrists and researche...
(Date:12/2/2009)...Newswire/ -- Reportlinker.com announces that a new...gue: ,, Drug Discovery Technologies - A Global..., http://www.reportlinker.com/p0164246/Drug-Disco...ds--Opportunities.html ,, Drug discovery has b...rmaceutical company,s business strategy. There are...
Breaking Biology Technology:Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH) 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9
...ce to Work" Around the World, RESEARCH TRIANGLE P... by the Great Places to Work(R) (GPTW) Institute a...in Brazil. The 2008 rankings were,recently publish...ost,widely read publications in the country., Ear...TW Institute,s,"Best Workplace" rankings in India,...
...Trends Research Group, Inc. is,pleased to announce...rs.,This is the first report in a series conducted...of an on-line survey completed by 150 Anemia Manag...orking with later stage,Chronic Kidney Disease (CK...set of 25 respondents. The report focuses on the m...
...ncreased efficacy driving demand for facet ...up, WALTHAM, Mass., Sept. 11 According to Millen...ly Invasive Spine Technologies,2008 report, the fa...bolts,and allograft implants, will grow at a compo...12. This high growth rate is due to increasing ado...
Other Biology Technology:Quintiles Recognized Among 'Best Companies to Work For' in Brazil 2New Study by BioTrends Highlights Anemia Practice Patterns According to Anemia Managers in Both Dialysis Units and CKD Clinics/Offices 2New Study by BioTrends Highlights Anemia Practice Patterns According to Anemia Managers in Both Dialysis Units and CKD Clinics/Offices 3US Facet Fixation Market to Increase by Over 60% Annually Through 2012 2US Facet Fixation Market to Increase by Over 60% Annually Through 2012 3
(Date:12/3/2009)...rs must be included in the design of the upcoming ...nitarian crisis, according to a scientist at the U..., Dr Simon Lewis argues that at least 50% of the c...known as REDD (Reducing Emissions from Deforestati...lers directly, and their property rights assured. ...
(Date:12/3/2009)...team of scientists from the U.S. Department of Ene...d University, and the Indian Institute of Science ...es locate the genetic information in DNA that is n...es. The research, published in the December 1, 200...y , confirms that many proteins responsible for in...
(Date:12/2/2009)...HIA Less acculturated Latino men have a more diff...e acculturated to U.S. culture, but acculturation ... Details of these findings are published in Cance...l of the American Association for Cancer Research..... , "Acculturation affects smoking cessation dif...
Breaking Biology News(10 mins):Forest deal at Copenhagen must avoid creating 'carbon refugees' 2Grooving down the helix 2Grooving down the helix 3Acculturation affects smoking cessation success among Latinos 2King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non Therapeutic Use 4649 1King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non Therapeutic Use 4649 2King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non Therapeutic Use 4649 3King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non Therapeutic Use 4649 4King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non Therapeutic Use 4649 5King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non Therapeutic Use 4649 6Doctors to Obama 3A Well Quit Before We Practice Government Medicine 50045 1Doctors to Obama 3A Well Quit Before We Practice Government Medicine 50045 2DuPont and Bayer CropScience Expand Collaboration With Broad License Agreements 12786 1DuPont and Bayer CropScience Expand Collaboration With Broad License Agreements 12786 2DuPont and Bayer CropScience Expand Collaboration With Broad License Agreements 12786 3DuPont and Bayer CropScience Expand Collaboration With Broad License Agreements 12786 4
...umors common in the genetic disorder neurofibromat...on and provides unique insight,into tumor developm...hers at Washington University School of Medicine i...the team made two important,discoveries: New blood...to the initial formation of tumors and therefore m...
...tory (MBL) has published the results of an EPA-fun... that, when combined, the pollutants,bromoform, ch...tail,known as BCE--can act synergistically to alte... scientists have previously studied the effects,of...time anyone has,demonstrated that BCE,s components...
...ished in the Journal of Virology, show that sex ho... female mice to the herpes simplex virus, type 2 (...ed diseases. , Charu Kaushic, assistant professor...on of this work is quite significant. "The researc...that in female mice, sex hormones have a profound ...
Other Biology News:Mouse brain tumors mimic those in human genetic disorder 2Mouse brain tumors mimic those in human genetic disorder 3Study identifies predictors of HIV drug resistance in patients beginning triple therapy 2Study identifies predictors of HIV drug resistance in patients beginning triple therapy 3Female sex hormones play a vital role in defense against sexually transmitted diseases 2Female sex hormones play a vital role in defense against sexually transmitted diseases 3
...s and reagents for convenient sample preparation t...tively disrupt cells and tissues.Clean up samples ... volumes. Accurately quantitate protein for first-...ly qualified for use in 2-D electrophoresis.High p...
Goat Anti-PAPAIN Polyclonal Antibody, Unconjugated from AbD Serotec
Rabbit Anti-Human IFN-Alpha / Beta R2 (IFNAR2) (CD118) Neutralizing Polyclonal Antibody, Unconjugated from PBL InterferonSource
ImageQuant 400 from GE Healthcare, formerly Amersham Biosciences
Biology Products: